1-kestose

01/01/2023 - "This randomised, double-blind, placebo-controlled pilot trial investigated the efficacy of 1-kestose against active ulcerative colitis. "
01/01/2023 - "Oral 1-kestose is well tolerated and provides clinical improvement for patients with mild to moderate ulcerative colitis through modulation of the gut microbiome."
01/01/2023 - "Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study."
01/01/2023 - "Whether administering prebiotic 1-kestose is effective for active ulcerative colitis remains controversial. "
01/01/2023 - "Letter: 1-kestose, the smallest fructooligosaccharide component, protection for mild to moderate ulcerative colitis patients."

08/27/2021 - "In the preliminary study using rats, the hyperinsulinemia induced by high-fat diet was suppressed by intake of water with 2% (w/v) 1-kestose. "

07/24/2023 - "In this study, the effect of 1-kestose (kestose), which has excellent bifidobacterial growth properties, on constipation in kindergarten children (n = 11) was compared with that of maltose (n = 12) in a randomized, double-blind study. "

01/01/2021 - "Increase in muscle mass associated with the prebiotic effects of 1-kestose in super-elderly patients with sarcopenia."

08/27/2021 - "These results suggest that prebiotic intervention using 1-kestose may potentially ameliorate insulin resistance in overweight humans via the modulation of the gut microbiota. "